[183] Yu J, Yu XL, Han ZY, et al. Percutaneous
cooled-probe microwave versus radiofrequency ablation in early-stage
hepatocellular carcinoma: a phase III randomised controlled trial[J]. Gut,
2017, 66(6): 1172-3. [184] Tan W, Deng Q, Lin S, et al. Comparison of
microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a
systematic review and meta-analysis[J]. Int J Hyperthermia, 2019, 36(1):
264-72. [185] Di Vece F, Tombesi P, Ermili F, et al.
Coagulation areas produced by cool-tip radiofrequency ablation and microwave
ablation using a device to decrease back-heating effects: a prospective pilot
study[J]. Cardiovasc Intervent Radiol, 2014, 37(3): 723-9. [186] Lin SM, Lin CJ, Lin CC, et al. Randomised
controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous
ethanol injection, and percutaneous acetic acid injection to treat
hepatocellular carcinoma of 3 cm or less[J]. Gut, 2005, 54(8): 1151-6. [187] Ahmed M, Solbiati L, Brace CL, et al.
Image-guided tumor ablation: standardization of terminology and reporting
criteria--a 10-year update[J]. Radiology, 2014, 273(1): 241-60. [188] Li L, Wang W, Pan H, et al. Microwave ablation
combined with OK-432 induces Th1-type response and specific antitumor immunity
in a murine model of breast cancer[J]. J Transl Med, 2017, 15(1): 23. [189] Mizukoshi E, Yamashita T, Arai K, et al.
Enhancement of tumor-associated antigen-specific T cell responses by
radiofrequency ablation of hepatocellular carcinoma[J]. Hepatology, 2013,
57(4): 1448-57. [190] Slovak R, Ludwig JM, Gettinger SN, et al.
Immuno-thermal ablations - boosting the anticancer immune response[J]. J
Immunother Cancer, 2017, 5(1): 78. [191] Duan X, Wang M, Han X, et al. Combined use of microwave ablation
and cell mmunotherapy induces nonspecific immunity of hepatocellular carcinoma
model mice[J]. Cell Cycle, 2020, 19(24): 3595-607. [192] Rozeman EA, Prevoo W, Meier MaJ, et al. Phase Ib/II trial testing
combined radiofrequency ablation and ipilimumab in uveal melanoma
(SECIRA-UM)[J]. Melanoma Res, 2020, 30(3): 252-60. [193] Lencioni R, De Baere T, Soulen MC, et al. Lipiodol transarterial chemoembolization
for hepatocellular carcinoma: A systematic review of efficacy and safety
data[J]. Hepatology, 2016, 64(1): 106-16. [194] Pelletier G, Ducreux M, Gay F, et al. Treatment of unresectable
hepatocellular carcinoma with lipiodol chemoembolization: a
multicenter randomized trial. Groupe CHC[J]. J Hepatol, 1998, 29(1): 129-34. [195] Lo CM, Ngan H, Tso WK, et al. Randomized
controlled trial of transarterial lipiodol chemoembolization for unresectable
hepatocellular carcinoma[J]. Hepatology, 2002, 35(5): 1164-71. [196] Llovet JM, Real MI, Montana X, et al. Arterial
embolisation or chemoembolisation versus symptomatic treatment in patients with
unresectable hepatocellular carcinoma: a randomised controlled trial[J].
Lancet, 2002, 359(9319):1734-9. [197] Camma C,
Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable
hepatocellular carcinoma: meta-analysis of randomized controlled trials[J].
Radiology, 2002, 224(1): 47-54. [198] Llovet JM, Bruix J. Systematic review of
randomized trials for unresectable hepatocellular carcinoma: Chemoembolization
improves survival[J]. Hepatology, 2003, 37(2): 429-42. [199] 中华医学会放射学分会介入学组协作组. 原发性肝细胞癌经导管肝动脉化疗性栓塞治疗技术操作规范专家共识[J]. 中华放射学杂志, 2011, 45(10): 908-12. [200] 中国医师协会介入医师分会临床诊疗指南专委会. 中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南(2021 年版)[J]. 中华医学杂志, 2021, 101(24):1848-62. [201] 中国抗癌协会肿瘤介入专家委员会. 经导管动脉灌注化疗药物应用原则——中国肿瘤介入专家共识[J]. 介入放射学杂志, 2017, 26(11): 963-70. [202] 郭志, 滕皋军, 邹英华, 等. 载药微球治疗原发性和转移性肝癌的技术操作推荐[J]. 中华放射学杂志, 2019, 53(5): 336-40. [203] Miyayama S, Matsui O. Superselective
Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma:
Rationale, Technique, and Outcome[J]. J Vasc Interv Radiol, 2016, 27(9):
1269-78. [204] Pung L, Ahmad M, Mueller K, et al. The Role of
Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular
Carcinoma: A Systematic Review and Meta-analysis[J]. J Vasc Interv Radiol,
2017, 28(3): 334-41. [205] Liang B, Makamure J, Shu S, et al. Treatment
Response, Survival, and Safety of ransarterial Chemoembolization With
CalliSpheres(®) icrospheres Versus Conventional
Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis[J].
Front Oncol, 2021, 11: 576232. [206] Si ZM, Wang GZ, Qian S, et al. Combination
Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave
Ablation Immediately Followed by Transarterial Chemoembolization[J]. J Vasc
Interv Radiol, 2016, 27(10):1577-83. [207] Lewis AR, Padula CA, Mckinney JM, et al.
Ablation plus Transarterial Embolic Therapy for Hepatocellular Carcinoma Larger
than 3 cm: Science, Evidence, and Future Directions[J]. Semin Intervent Radiol,
2019, 36(4): 303-9. [208] Huo YR, Eslick GD. Transcatheter Arterial Chemoembolization
Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma:
A Systematic Review and Meta-analysis[J]. JAMA Oncol, 2015, 1(6):756-65. [209] 中华医学会放射肿瘤学分会, 中国生物医学工程学会精确放疗分会肝癌学组与消化系统肿瘤专家委员会, 中国研究型医院学会放射肿瘤学分会肝癌学组. 2016 年原发性肝癌放疗共识[J]. 中华放射肿瘤学杂志, 2016, 25(11): 1141-50. [210] Jang JW, Choi JY, Bae SH, et al. Transarterial
chemo-lipiodolization can reactivate hepatitis B virus replication in patients
with hepatocellular carcinoma[J]. J Hepatol, 2004, 41(3): 427-35. [211] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019 年版)[J]. 中华肝脏病杂志, 2019, 27(12): 938-61. [212] Yang M, Fang Z, Yan Z, et al. Transarterial
chemoembolisation (TACE) combined with endovascular implantation of an
iodine-125 seed strand for the treatment of hepatocellular carcinoma with
portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical
trial[J]. J Cancer Res Clin Oncol, 2014, 140(2): 211-9. [213] 胡鸿涛, 黎海亮, 郭晨阳, 等. 125I 粒子植入联合动脉化学栓塞治疗原发性肝癌合并门静脉癌栓[J]. 中华放射学杂志, 2012, 46(6): 552-6. [214] Zhang ZH, Zhang W, Gu JY, et al. Treatment of
Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed
Strand Implantation and Transarterial Chemoembolization: A Propensity-Score
Analysis[J]. J Vasc Interv Radiol, 2018, 29(8): 1085-93. [215] Chen YX, Zhuang Y, Yang P, et al. Helical
IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression
Technique and Modified Fractionation Regimen for Small Hepatocellular
Carcinoma[J]. Technol Cancer Res Treat, 2020, 19: 1533033820937002. [216] Chino F, Stephens SJ, Choi SS, et al. The role
of external beam radiotherapy in the treatment of hepatocellular cancer[J].
Cancer, 2018, 124(17): 3476-89. [217] Hara K, Takeda A, Tsurugai Y, et al.
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to
Radiofrequency Ablation: A Propensity Score Analysis[J]. Hepatology, 2019,
69(6): 2533-45.
|
